


Compounded semaglutide is a once-weekly injectable GLP-1 medication designed to curb appetite and reduce cravings to support weight management.
Prescribed only after a licensed provider reviews your health history and goals, it's compounded specifically for you at a licensed U.S. pharmacy, with your provider gradually increasing your dose over time to help manage side effects.


• Once-weekly injectable GLP-1 medication
• Compounded, patient-specific formulation (not FDA-approved as compounded)
• Prescribed only after licensed provider review; free evaluation, charged only if prescribed
• Compounded in a 503(A) or 503(B) licensed U.S. pharmacy
Henry Meds is a telehealth platform built to make treatment for weight management, hormone therapy, and other chronic conditions fast, easy, and affordable — no insurance required. Founded in 2022, Henry connects patients with licensed healthcare providers who review their health history and goals, then ship prescribed medication directly to their door if approved.
The platform charges one flat monthly fee covering provider visits, medication, supplies, and ongoing care, aiming to make treatment accessible to people who've been priced out or left behind by the traditional commercial healthcare market.